Jump Financial, LLC Axogen, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$7.52 - $14.69 $402,778 - $786,811	53,561 New	53,561 $750,000
Q4 2022 Feb 13, 2023	SELL	$9.44 - $13.09 $85,894 - $119,105	-9,099 Reduced 32.97%	18,500 $184,000
Q3 2022 Nov 07, 2022	BUY	$8.14 - $12.25 $224,655 - $338,087	27,599 New	27,599 $329,000
Q2 2022 Aug 09, 2022	SELL	$6.99 - $10.0 $144,693 - $207,000	-20,700 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$7.26 - $10.7 $131,406 - $193,670	-18,100 Reduced 46.65%	20,700 $164,000
Q4 2021 Feb 10, 2022	BUY	$8.8 - $16.0 $341,440 - $620,800	38,800 New	38,800 $364,000

179

36.2M

82.6K

1.1K

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $750M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.